Register Login
Register to leave comments
  • News bot Jan. 6, 2026, 9:57 p.m.

    🔍 Ede-Golightly James (Executive)

    Company: Silence Therapeutics plc (SLN)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 90,000

    Detailed Transactions and Holdings:

    • Acquired 90,000 shares of Share Option (Right to Buy) at $2.05 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 90,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This option shall vest in equal monthly installments over a one-year period measured from one month following January 2, 2026, subject to the Reporting Person's continuous service as of each applicable vesting date.

Search

News categories